Evidence map›Paper›PMID 20800616›Full record

ArticleNeurotoxicology2010

MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

Shane A Perrine, Farhad Ghoddoussi, Mark S Michaels, Elisabeth M Hyde, Donald M Kuhn, Matthew P Galloway

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neurotoxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shane A PerrineDepartment of Psychiatry and Behavioral Neurosciences, Brain Research and Imaging Neuroscience Division, Wayne State University School of Medicine, Detroit, MI 48201, USA. sperrine@med.wayne.edu
Farhad Ghoddoussi
Mark S Michaels
Elisabeth M Hyde
Donald M Kuhn
Matthew P Galloway
Wayne State University · US

Funding

High Field MRS Assessment of Stimulant Exposure in RatsR01DA016736 · NIDA · WAYNE STATE UNIVERSITY · PI GALLOWAY, MATTHEW P. · 2004 to 2007
$1.2M
MR Spectroscopy and Behavior after Clinically Relevant Administration of MDMAK01DA024760 · NIDA · WAYNE STATE UNIVERSITY · PI PERRINE, SHANE ALAN · 2008 to 2012
$772k
NIDA NIH HHS K01 DA024760NIDA NIH HHS K01-DA024760NIDA NIH HHS R01 DA016736NIDA NIH HHS R01-DA016736
6 · The paper itself

Abstract

In animals, repeated administration of 3,4-methylenedioxymethamphetamine (MDMA) reduces markers of serotonergic activity and studies show similar serotonergic deficits in human MDMA users. Using proton-magnetic resonance spectroscopy ((1)H-MRS) at 11.7Tesla, we measured the metabolic neurochemical profile in intact, discrete tissue punches taken from prefrontal cortex, anterior striatum, and hippocampus of rats administered MDMA (5mg/kg IP, 4× q 2h) or saline and euthanized 7 days after the last injection. Monoamine content was measured with HPLC in contralateral punches from striatum and hippocampus to compare the MDMA-induced loss of 5HT innervation with constituents in the (1)H-MRS profile. When assessed 7 days after the last MDMA injection, levels of hippocampal and striatal serotonin (5HT) were significantly reduced, consistent with published animal studies. N-Acetylaspartate (NAA) levels were significantly increased in prefrontal cortex and not affected in anterior striatum or hippocampus; myo-inositol (INS) levels were increased in prefrontal cortex and hippocampus but not anterior striatum. Glutamate levels were increased in prefrontal cortex and decreased in hippocampus, while GABA levels were decreased only in hippocampus. The data suggest that NAA may not reliably reflect MDMA-induced 5HT neurotoxicity. However, the collective pattern of changes in 5HT, INS, glutamate and GABA is consistent with persistent hippocampal neuroadaptations caused by MDMA.

Indexed as

AnimalsAspartic AcidBrainBrain ChemistryMaleN-Methyl-3,4-methylenedioxyamphetamineRatsRats, Sprague-DawleySerotoninSerotonin AntagonistsAspartic AcidN-acetylaspartateN-Methyl-3,4-methylenedioxyamphetamineSerotoninSerotonin Antagonists

Identifiers

PMID20800616
PMCPMC2974051
OpenAlexW2058065177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.